Circulating miR-21, miR-146a and Fas ligand respond to postmenopausal estrogen-based hormone replacement therapy - A study with monozygotic twin pairs

Reeta Kangas, Eija Pöllänen, Maria Rita Rippo, Catia Lanzarini, Francesco Prattichizzo, Paula Niskala, Juulia Jylhävä, Sarianna Sipilä, Jaakko Kaprio, Antonio Domenico Procopio, Miriam Capri, Claudio Franceschi, Fabiola Olivieri, Vuokko Kovanen

Research output: Contribution to journalArticle

Abstract

Biological aging is associated with physiological deteriorations, which are partly due to changes in the hormonal profile. MicroRNAs regulate various processes associated with cell senescence; differentiation, replication and apoptosis. Serum microRNAs have potential to serve as noninvasive markers for diagnostics/prognostics and therapeutic targets.We analysed the association of estrogen-based hormone replacement therapy (HRT) with selected microRNAs and inflammation markers from the serum, leukocytes and muscle biopsy samples from 54 to 62 year-old postmenopausal monozygotic twins (n=. 11 pairs) discordant for HRT usage. Premenopausal 30-35 year-old women (n=. 8) were used as young controls. We focused on the hormonal aging and on the interaction between HRT use and the modulation of miR-21, miR-146a and classical inflammation markers. Fas-ligand was analysed since it functions in both apoptosis and inflammation.The inflammatory profile was healthier among the premenopausal women compared to the postmenopausal twins. Serum miR-21 and miR-146a levels and FasL concentrations were lower in HRT users compared to their non-using co-twins, demonstrating their responsiveness to HRT. Based on the pairwise FasL analysis, FasL concentration is likely to be genetically controlled. Overall, we suggest that postmenopausal estrogen deficiency sustains the development of "inflamm-aging". Estrogen sensitive, specific circulating microRNAs could be potential, early biomarkers for age-associated physiological deteriorations.

Original languageEnglish
Pages (from-to)1-8
Number of pages8
JournalMechanisms of Ageing and Development
Volume143-144
DOIs
Publication statusPublished - Dec 5 2014

Fingerprint

Fas Ligand Protein
Monozygotic Twins
Hormone Replacement Therapy
Estrogens
MicroRNAs
Inflammation
Biomarkers
Apoptosis
Cell Aging
Serum
Leukocytes
Biopsy
Muscles

Keywords

  • "Inflamm-aging"
  • Apoptosis
  • Estrogen
  • Hormone replacement therapy
  • Micrornas

ASJC Scopus subject areas

  • Ageing
  • Developmental Biology
  • Medicine(all)

Cite this

Circulating miR-21, miR-146a and Fas ligand respond to postmenopausal estrogen-based hormone replacement therapy - A study with monozygotic twin pairs. / Kangas, Reeta; Pöllänen, Eija; Rippo, Maria Rita; Lanzarini, Catia; Prattichizzo, Francesco; Niskala, Paula; Jylhävä, Juulia; Sipilä, Sarianna; Kaprio, Jaakko; Procopio, Antonio Domenico; Capri, Miriam; Franceschi, Claudio; Olivieri, Fabiola; Kovanen, Vuokko.

In: Mechanisms of Ageing and Development, Vol. 143-144, 05.12.2014, p. 1-8.

Research output: Contribution to journalArticle

Kangas, Reeta ; Pöllänen, Eija ; Rippo, Maria Rita ; Lanzarini, Catia ; Prattichizzo, Francesco ; Niskala, Paula ; Jylhävä, Juulia ; Sipilä, Sarianna ; Kaprio, Jaakko ; Procopio, Antonio Domenico ; Capri, Miriam ; Franceschi, Claudio ; Olivieri, Fabiola ; Kovanen, Vuokko. / Circulating miR-21, miR-146a and Fas ligand respond to postmenopausal estrogen-based hormone replacement therapy - A study with monozygotic twin pairs. In: Mechanisms of Ageing and Development. 2014 ; Vol. 143-144. pp. 1-8.
@article{3e85353014054b82957c3df84821fd3a,
title = "Circulating miR-21, miR-146a and Fas ligand respond to postmenopausal estrogen-based hormone replacement therapy - A study with monozygotic twin pairs",
abstract = "Biological aging is associated with physiological deteriorations, which are partly due to changes in the hormonal profile. MicroRNAs regulate various processes associated with cell senescence; differentiation, replication and apoptosis. Serum microRNAs have potential to serve as noninvasive markers for diagnostics/prognostics and therapeutic targets.We analysed the association of estrogen-based hormone replacement therapy (HRT) with selected microRNAs and inflammation markers from the serum, leukocytes and muscle biopsy samples from 54 to 62 year-old postmenopausal monozygotic twins (n=. 11 pairs) discordant for HRT usage. Premenopausal 30-35 year-old women (n=. 8) were used as young controls. We focused on the hormonal aging and on the interaction between HRT use and the modulation of miR-21, miR-146a and classical inflammation markers. Fas-ligand was analysed since it functions in both apoptosis and inflammation.The inflammatory profile was healthier among the premenopausal women compared to the postmenopausal twins. Serum miR-21 and miR-146a levels and FasL concentrations were lower in HRT users compared to their non-using co-twins, demonstrating their responsiveness to HRT. Based on the pairwise FasL analysis, FasL concentration is likely to be genetically controlled. Overall, we suggest that postmenopausal estrogen deficiency sustains the development of {"}inflamm-aging{"}. Estrogen sensitive, specific circulating microRNAs could be potential, early biomarkers for age-associated physiological deteriorations.",
keywords = "{"}Inflamm-aging{"}, Apoptosis, Estrogen, Hormone replacement therapy, Micrornas",
author = "Reeta Kangas and Eija P{\"o}ll{\"a}nen and Rippo, {Maria Rita} and Catia Lanzarini and Francesco Prattichizzo and Paula Niskala and Juulia Jylh{\"a}v{\"a} and Sarianna Sipil{\"a} and Jaakko Kaprio and Procopio, {Antonio Domenico} and Miriam Capri and Claudio Franceschi and Fabiola Olivieri and Vuokko Kovanen",
year = "2014",
month = "12",
day = "5",
doi = "10.1016/j.mad.2014.11.001",
language = "English",
volume = "143-144",
pages = "1--8",
journal = "Mechanisms of Ageing and Development",
issn = "0047-6374",
publisher = "Elsevier Ireland Ltd",

}

TY - JOUR

T1 - Circulating miR-21, miR-146a and Fas ligand respond to postmenopausal estrogen-based hormone replacement therapy - A study with monozygotic twin pairs

AU - Kangas, Reeta

AU - Pöllänen, Eija

AU - Rippo, Maria Rita

AU - Lanzarini, Catia

AU - Prattichizzo, Francesco

AU - Niskala, Paula

AU - Jylhävä, Juulia

AU - Sipilä, Sarianna

AU - Kaprio, Jaakko

AU - Procopio, Antonio Domenico

AU - Capri, Miriam

AU - Franceschi, Claudio

AU - Olivieri, Fabiola

AU - Kovanen, Vuokko

PY - 2014/12/5

Y1 - 2014/12/5

N2 - Biological aging is associated with physiological deteriorations, which are partly due to changes in the hormonal profile. MicroRNAs regulate various processes associated with cell senescence; differentiation, replication and apoptosis. Serum microRNAs have potential to serve as noninvasive markers for diagnostics/prognostics and therapeutic targets.We analysed the association of estrogen-based hormone replacement therapy (HRT) with selected microRNAs and inflammation markers from the serum, leukocytes and muscle biopsy samples from 54 to 62 year-old postmenopausal monozygotic twins (n=. 11 pairs) discordant for HRT usage. Premenopausal 30-35 year-old women (n=. 8) were used as young controls. We focused on the hormonal aging and on the interaction between HRT use and the modulation of miR-21, miR-146a and classical inflammation markers. Fas-ligand was analysed since it functions in both apoptosis and inflammation.The inflammatory profile was healthier among the premenopausal women compared to the postmenopausal twins. Serum miR-21 and miR-146a levels and FasL concentrations were lower in HRT users compared to their non-using co-twins, demonstrating their responsiveness to HRT. Based on the pairwise FasL analysis, FasL concentration is likely to be genetically controlled. Overall, we suggest that postmenopausal estrogen deficiency sustains the development of "inflamm-aging". Estrogen sensitive, specific circulating microRNAs could be potential, early biomarkers for age-associated physiological deteriorations.

AB - Biological aging is associated with physiological deteriorations, which are partly due to changes in the hormonal profile. MicroRNAs regulate various processes associated with cell senescence; differentiation, replication and apoptosis. Serum microRNAs have potential to serve as noninvasive markers for diagnostics/prognostics and therapeutic targets.We analysed the association of estrogen-based hormone replacement therapy (HRT) with selected microRNAs and inflammation markers from the serum, leukocytes and muscle biopsy samples from 54 to 62 year-old postmenopausal monozygotic twins (n=. 11 pairs) discordant for HRT usage. Premenopausal 30-35 year-old women (n=. 8) were used as young controls. We focused on the hormonal aging and on the interaction between HRT use and the modulation of miR-21, miR-146a and classical inflammation markers. Fas-ligand was analysed since it functions in both apoptosis and inflammation.The inflammatory profile was healthier among the premenopausal women compared to the postmenopausal twins. Serum miR-21 and miR-146a levels and FasL concentrations were lower in HRT users compared to their non-using co-twins, demonstrating their responsiveness to HRT. Based on the pairwise FasL analysis, FasL concentration is likely to be genetically controlled. Overall, we suggest that postmenopausal estrogen deficiency sustains the development of "inflamm-aging". Estrogen sensitive, specific circulating microRNAs could be potential, early biomarkers for age-associated physiological deteriorations.

KW - "Inflamm-aging"

KW - Apoptosis

KW - Estrogen

KW - Hormone replacement therapy

KW - Micrornas

UR - http://www.scopus.com/inward/record.url?scp=84919388514&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84919388514&partnerID=8YFLogxK

U2 - 10.1016/j.mad.2014.11.001

DO - 10.1016/j.mad.2014.11.001

M3 - Article

C2 - 25448133

AN - SCOPUS:84919388514

VL - 143-144

SP - 1

EP - 8

JO - Mechanisms of Ageing and Development

JF - Mechanisms of Ageing and Development

SN - 0047-6374

ER -